aTYR PHARMA INC: cashflow_financing

Value{"amount": 24857000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2021-01-01 – 2021-03-31
Statuscurrent
EntityaTYR PHARMA INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-21-028014 · Open the official SEC filing →
Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001339970/cashflow-financing/2021-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/52727ff8-3df8-4c9e-9f9c-b5f2e9c3ce5c

History

From the Record